09/30/2024
5:01 AM | Addex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/19/2024
5:05 AM | Addex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024
5:05 AM | Addex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
7:12 PM | Addex Therapeutics (Subject)
Growth Equity Opportunities Fund IV, LLC (Filed by)
| Form SC 13D/A | |
08/05/2024
8:00 PM | Addex Therapeutics (Subject)
Growth Equity Opportunities Fund IV, LLC (Filed by)
| Form SC 13D/A | |
07/22/2024
5:05 AM | Addex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024
5:05 AM | Addex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
07/01/2024
5:05 AM | Addex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2024
5:00 AM | Addex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2024
5:05 AM | Addex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
5:05 AM | Addex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024
11:15 PM | Addex Therapeutics (Filer)
| Form EFFECT | |
04/18/2024
5:15 AM | Addex Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/18/2024
5:05 AM | Addex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/03/2024
5:05 AM | Addex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/30/2024
3:58 PM | Addex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/30/2024
4:00 PM | Addex Therapeutics (Filer)
| Form 424B5 | |
12/21/2023
5:00 AM | Addex Therapeutics (Filer)
| Form 6-K/A | |
12/20/2023
5:05 AM | Addex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023
5:05 AM | Addex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/08/2023
1:11 PM | Addex Therapeutics (Subject)
Growth Equity Opportunities Fund IV, LLC (Filed by)
| Form SC 13D/A | |
11/29/2023
11:15 PM | Addex Therapeutics (Filer)
| Form EFFECT | |
11/29/2023
5:27 AM | Addex Therapeutics (Filer)
| Form POS AM | |
11/29/2023
5:00 AM | Addex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/28/2023
5:05 AM | Addex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
